25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

<div>25-OH vitamin D3 (ng mL<sup>−1</sup>) serum level in melanoma patients for individuals with normal and high serum IL-8 (pg mL<sup>−1</sup>). Prevalence depicts the subgroups of melanoma patients with high serum IL-8 congregating in the low serum 25-OH vitamin D3 ranges.</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: 25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression 